Kennedy Capital Management, Inc. Imago Bio Sciences, Inc. Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$15.03 - $35.96 $9,393 - $22,475	-625 Reduced 1.35%	45,756 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $1,202 - $1,657	-85 Reduced 0.18%	46,381 $698,000
Q2 2022 Aug 10, 2022	SELL	$11.81 - $20.92 $4,700 - $8,326	-398 Reduced 0.85%	46,466 $622,000
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $119,451 - $175,975	-7,039 Reduced 13.06%	46,864 $903,000
Q4 2021 Feb 14, 2022	SELL	$16.22 - $29.69 $85,738 - $156,941	-5,286 Reduced 8.93%	53,903 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $947,024 - $1.71 Million	59,189 New	59,189 $1.19 Million

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.